| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.29 | 0.09 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |